McKesson Corp. (MCK)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Apr 11, 2025

$689.36

P/E Ratio

31.60

Market Cap

$86.39B

Apr 23, 2024May 29, 2024Jul 2, 2024Aug 2, 2024Sep 5, 2024Oct 8, 2024Nov 8, 2024Dec 13, 2024Jan 22, 2025Feb 26, 2025Apr 11, 2025$450.00$500.00$550.00$600.00$650.00$700.00$750.00
  • MCK
Description
Add to research
View more

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Metrics
Add to research
View more

Overview

  • HQIrving, TX
  • SectorDistribution Services
  • IndustryMedical Distributors
  • TickerMCK
  • Price$689.36+1.48%

Trading Information

  • Market cap$86.39B
  • Float99.91%
  • Average Daily Volume (1m)1,199,446
  • Average Daily Volume (3m)968,871
  • EPS$21.95

Company

  • Revenue$344.58B
  • Rev growth (1yr)17.80%
  • Net income$879.00M
  • Gross margin3.38%
  • EBITDA margin1.51%
  • EBITDA$1.44B
  • EV$81.01B
  • EV/Revenue0.24
  • P/E31.60
  • P/S0.25
  • P/BN/A
  • Debt/EquityN/A
Documents
Add to research
View more